English Archives - Sidra Medicine

Malek Abu Safieh

Dr. Aby Safieh is the Chief of Audiology at Sidra Medicine, with over 20 years of experience in diagnosing and managing complex hearing and balance disorders across all age groups. He is particularly recognized for his expertise in pediatric and syndromic cases, vestibular dysfunction, cochlear and osseointegrated implants, and audiological challenges related to oncology and genetic conditions.

At Sidra Medicine, Dr. Safieh leads several key initiatives, including newborn hearing screening programs and early intervention pathways, especially for NICU patients. Prior to joining Sidra Medicine in 2022, he served as Assistant Professor and Program Coordinator at the American University of Beirut, where he also supervised clinical training at the AUB Medical Center.

A committed educator, he trains audiologists, ENT residents, and students in evidence-based practice. Dr. Safieh has contributed to peer-reviewed publications and international conferences, focusing on multidisciplinary care models and advancing clinical audiology service delivery.

03 June, 2025

Her Highness Sheikha Moza bint Nasser Inaugurates New Pediatric Hematopoietic Stem Cell Transplant Ward at Sidra Medicine

Her Highness Sheikha Moza bint Nasser, Chairperson of Qatar Foundation for Education, Science and Community Development, officially inaugurated the new pediatric Hematopoietic Stem Cell Transplant (HSCT) ward at Sidra Medicine, a Qatar Foundation entity.

27 May, 2025

Sidra Medicine First Hospital in the Middle East to Successfully Perform Intraventricular Baclofen Therapy

Sidra Medicine, a member of Qatar Foundation, is the first hospital in the Middle East to successfully perform two Intraventricular Baclofen Therapies. The milestone highlights Sidra Medicine’s commitment to pioneering advanced neurosurgical treatments for children and young people with severe movement disorders.

20 May, 2025

Sidra Medicine Performs Qatar’s First-Ever Osia® Implant Hearing Procedure

Sidra Medicine, a member of Qatar Foundation, has taken a pioneering step in auditory healthcare by successfully performing Qatar’s first implantation of the OSIA® OSI300 hearing device. The implant is a next-generation osseo-integrated hearing device that overcomes many limitations of older bone conduction systems.

13 May, 2025

Sidra Medicine Signs Memorandum of Understanding with Great Ormond Street Hospital

Sidra Medicine, a member of Qatar Foundation, has signed a Memorandum of Understanding (MoU) with Great Ormond Street Hospital for Children NHS Foundation Trust (GOSH), one of the world’s leading pediatric hospitals. The agreement focuses on collaboration across key areas of clinical service, research, and education in children’s health.

11 May, 2025

Sidra Medicine Hosts First Royal College of Paediatrics and Child Health (MRCPCH) Clinical Exam in Qatar

Sidra Medicine, a member of Qatar Foundation, has successfully hosted Qatar’s first Membership of the Royal College of Paediatrics and Child Health (MRCPCH) Clinical Exam. Fifteen examiners participated in the examination process, assessing 48 candidates from across the region, who are pursuing certification with the Royal College of Physicians (RCP).

05 May, 2025

Sidra Medicine Study Pioneers Genome Assembly Approach for Rare Disease Research

Researchers at Sidra Medicine, a member of Qatar Foundation, have led a landmark study, published in Nature Genetics, unlocking the genetic causes of difficult-to-resolve rare diseases from diverse Middle Eastern populations.

03 May, 2025

Sidra Medicine to Host Inaugural MENA ART Conference

Advancing Precision Medicine with Flow Cytometry and Optical Microscopy 3 May 2024, Doha, Qatar - Sidra Medicine, a member of Qatar Foundation, will host its inaugural MENA ART (Advanced Research

30 April, 2025

Sidra Medicine and Children’s Hospital Los Angeles Sign Memorandum of Understanding

Sidra Medicine, a member of Qatar Foundation, has signed a Memorandum of Understanding (MOU) with Children’s Hospital Los Angeles (CHLA), marking the beginning of a new collaboration between the two leading pediatric healthcare institutions.

29 April, 2025

Sidra Medicine Zebrafish Study Investigates Gene Linked to Autism and Epilepsy

Sidra Medicine and Qatar Biomedical Research Institute (QBRI) at Hamad Bin Khalifa University, have published a groundbreaking study marking the first creation of an autism zebrafish model in Qatar, to investigate a rare genetic mutation associated with both autism and epilepsy. The study highlights the power of precision medicine in advancing our understanding of complex neurodevelopmental disorders.